Disc Medicine IRON
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$2.77M (11 inflow days, 9 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.6% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 19.12% to 15.46% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +735,300 | 2.5% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +229,219 | 0.5% |
| abrdn plc | Mutual Fund | 2026/Q3 | +159,667 | 1.3% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +87,806 | 0.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +64,964 | 5.6% |
| Loomis, Sayles & Company L.P. | Mutual Fund | 2026/Q3 | +58,164 | 1.0% |
| Barclays PLC | Public Company | 2026/Q3 | +54,800 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +53,115 | 0.1% |
| Vestal Point Capital, LP | Hedge Fund | 2026/Q3 | +850,000 | 3.4% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +496,570 | 4.1% |
| Opaleye Management Inc. | Hedge Fund | 2026/Q3 | +434,000 | 1.9% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +326,049 | 4.1% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +315,000 | 1.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +194,068 | 5.6% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +174,571 | 1.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | William Savage | Chief Medical Officer | Automatic Disposition | -16,035 | $85.09 | 19,178 |
| 20 Oct 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -41,825 | $80.23 | 1,415,865 | |
| 14 Sep 2026 | John Quisel | Chief Executive Officer | Derivative Exercise and Retained | +36,000 | $1.01 | 114,929 |
| 10 Sep 2026 | Kevin Bitterman | Independent Director | Derivative Exercise and Sale | -27,136 | $70.11 | – |
| 3 Sep 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -1,689 | $79.96 | 1,457,690 | |
| 2 Sep 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -54,496 | $80.98 | 1,459,379 | |
| 24 Aug 2026 | Jonathan Yu | Chief Opearating Officer | Derivative Exercise and Sale | -9,096 | $83.12 | 10,242 |
| 16 Aug 2026 | John Quisel | Chief Executive Officer | Derivative Exercise and Sale | -33,000 | $79.84 | 78,929 |
| 11 Aug 2026 | Jonathan Yu | Chief Opearating Officer | Derivative Exercise and Sale | -804 | $82.64 | 10,242 |
| 5 Aug 2026 | Rahul Khara | Chief Legal Officer | Derivative Exercise and Sale | -5,000 | $80.00 | 17,324 |
| 12 Jul 2026 | John Quisel | Chief Executive Officer | Derivative Exercise and Sale | -33,000 | $76.05 | 78,929 |
| 6 Jul 2026 | Jonathan Yu | Chief Opearating Officer | Derivative Exercise and Sale | -100 | $82.50 | 10,242 |
| 28 Jun 2026 | Rahul Khara | Chief Legal Officer | Derivative Exercise and Sale | -2,500 | $75.00 | 17,173 |
| 25 Jun 2026 | Jonathan Yu | Chief Opearating Officer | Derivative Exercise and Sale | -300 | $72.50 | 10,242 |
| 21 Jun 2026 | Jonathan Yu | Chief Opearating Officer | Derivative Exercise and Sale | -9,700 | $72.66 | 10,242 |
| 17 Jun 2026 | Georges Gemayel | Independent Director | Other Derivative Acquisition | +6,212 | $70.79 | 6,212 |
| 17 Jun 2026 | Kevin Bitterman | Independent Director | Other Derivative Acquisition | +6,212 | $70.79 | 6,212 |
| 17 Jun 2026 | Liam Ratcliffe | Independent Director | Other Derivative Acquisition | +6,212 | $70.79 | 6,212 |
| 17 Jun 2026 | John Quisel | Chief Executive Officer | Derivative Exercise and Sale | -34,000 | $71.61 | 78,929 |
| 17 Jun 2026 | Mark Chin | Independent Director | Other Derivative Acquisition | +6,212 | $70.79 | 6,212 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,862,594 | 15.5% | 3.2 |
| 15 Oct 2026 | 7,457,523 | 19.4% | 10.6 |
| 30 Sep 2026 | 7,270,420 | 18.9% | 12.8 |
| 15 Sep 2026 | 7,207,702 | 18.8% | 13.6 |
| 31 Aug 2026 | 7,365,002 | 19.2% | 16.6 |
| 14 Aug 2026 | 7,342,568 | 19.1% | 24.8 |
No comments yet — be the first to weigh in on IRON.
Sign in to join the discussion.